These results were consistent with those of Uherek et al. and Liu et al., who developed HER2‐specific scFv expressing NK92 cells and showed that HER2‐CAR NK92 cells induced a considerable increase in destruction and growth inhibition HER2‐expressing cancer cells in vitro and in vivo.194, 195. This evidence concerns the gene ERBB2 and cancer.